Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial data
Pharma
Merck's Welireg again comes up short in OS but excels in PFS
Merck’s Welireg continues to show benefits in PFS but no significant improvement in overall survival when compared to Novartis’ chemotherapy Afinitor.
Kevin Dunleavy
Sep 13, 2024 8:00am
FDA noted 'large number' of missing AEs in Amgen's Imdelltra app
Aug 14, 2024 6:45am
ASCO: Bristol calls Roche and AZ's bets in 1L liver cancer
Jun 4, 2024 8:00am
ADC touts early Zynlonta results in marginal zone lymphoma
May 6, 2024 4:19pm
EyePoint reports Duravyu trial fail, raising questions
May 6, 2024 10:55am
AZ clinches early Calquence win in untreated MCL
May 2, 2024 10:24am
